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Abstract 
Plasmacytoid dendritic cells (PDC), which produce IFN-alpha in response to autoimmune 
complexes containing nuclear antigens are thought to be critically involved in the 
pathogenesis of systemic lupus erythematodes (SLE). One of the immunostimulatory 
components of SLE-IC is self-DNA, which is recognized through TLR9 in PDC and B 
cells. Small nuclear ribonucleoproteins (snRNP) are another major component of SLE 
immune complexes in 30 to 40 % of patients. In this study we show that murine PDC are 
activated by purifed U1snRNP/anti-Sm immune complexes to produce IFN-alpha and 
proinflammatory cytokines as well as upregulate costimulatory molecules. The induction 
of IFN-alpha and IL-6 by U1snRNP in murine bone marrow derived PDC required the 
presence of intact U1RNA and was largely dependent on TLR7 but independent of 
TLR3. Intracellularly delivered isolated U1snRNA and oligoribonucleotides derived from 
the stem loop regions and the Sm binding site of U1snRNA efficiently induced IFN-α 
and IL-6 in FL-DC in a TLR7-dependent manner. The U1snRNA component of 
U1snRNP immune complexes which are found in SLE patients acts as an endogenous 
“self” ligand for TLR7, triggering IFN-alpha and IL-6 production in PDC. 
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Introduction 
Systemic lupus erythematodes (SLE) is a prototypic autoimmune disorder affecting 
approximately 1 in 2000 individuals. The etiology of the disease is unknown – genetic 
susceptibility as well as environmental factors play a role. Defects in tolerance, apoptosis, 
clearance of immune complexes (IC) or generation of regulatory cells lead to 
uncontrolled hyperactivity of selfreactive T- and B-lymphocytes and to the sustained 
production of tissue damaging autoantibodies and IC. The presence of high levels of 
circulating autoantibodies against nuclear antigens is the immunological hallmark of 
SLE. Anti-dsDNA antibodies are found in 70 % of patients and high titers correlate with 
disease severity. 30 % of SLE-patients also have circulating anti-Sm antibodies 
recognizing the seven Sm proteins (B, D1, D2, D3, E, F, G) which are common to all 
small nuclear ribonucleoproteins (snRNP) and associate with U snRNA (U1, 2, 4, 5). 
Additionally, 40 % of SLE patients have anti-RNP antibodies, which specifically bind to 
the A, C and 70kD proteins within U1snRNPs 
1. It has been demonstrated that immune 
complexes containing nucleic acids can directly activate murine B lymphocytes and 
conventional DC as well as human plasmacytoid DC thus contributing to the 
development of full-blown SLE 
2-4. Type I interferon (IFN-α/-β), which is induced by 
SLE IC in vitro, is found at high levels in the serum of most patients with active SLE. 
Microarray analysis in peripheral blood mononuclear cells of SLE patients revealed the 
typical “IFN-signature” of gene expression, which correlated with disease activity 
5,6. 
There is strong evidence for a central role of IFN-α/β in SLE pathogenesis from studies 
in the New Zealand Black (NZB)/New Zealand White (NZW) mouse model of lupus 
7,8, 
whereas conflicting results were obtained in the Fas
lpr mouse model of lupus-like disease 
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9,10. The SLE-promoting role of IFN-α/β may be attributed to the support of B cell 
differentiation and antibody production 
11,12, as well as to the induction of dendritic cell 
(DC) differentiation and maturation 
13. Plasmacytoid DC (PDC), which have been 
identified as the major source of IFN-α/β in SLE 
14 are thought to be important players in 
this systemic autoimmune disorder 
15,16. Apart from IFN-α, IL-6, which is produced by 
PDC and other cell types has also been implicated in the pathogenesis of SLE, because it 
induces plasma cell and effector T cell differentiation and blocks the activity of 
CD4+CD25+ regulatory T cells 
17,18.  
 
Altogether these data raise the question, which receptors are involved in the recognition 
of SLE IC. In a recent study DNA-containing IC isolated from sera of SLE patients or 
generated experimentally have been shown to trigger Toll-like receptor (TLR)-9 - the 
receptor for bacterial CpG DNA - in B lymphocytes and DC 
4,19,20. Activation of TLR9 
by “self” DNA requires endosomal translocation. This is achieved by Fc receptor or B 
cell receptor mediated endocytosis of DNA-containing IC and can be mimicked by 
cationic lipid mediated transport 
4,20,21. Interestingly, TLR9-independent activation of 
myeloid DC by anti-nucleosome IC has also been observed 
19. This may be attributed to 
an as of yet unidentified DNA recognition mechanism or to additional stimulatory 
components within nucleosomes. A recent study found that IFN-α induction in PDC by 
complexes generated from necrotic cell material and SLE-IgG was sensitive to RNAse 
pretreatment 
3. Since snRNPs (specifically U1snRNP) are the major SLE autoantigens 
besides dsDNA, we investigated their stimulatory potential for murine PDC. In this 
study, we show that purified U1snRNP complexed with cationic lipid or anti-Sm 
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autoantibody as well as intracellularly delivered isolated U1snRNA induce robust type I 
IFN and inflammatory cytokine responses in murine BM-derived DC and PDC. Thus in 
murine dendritic cells the U1snRNA within U1snRNP autoimmune complexes acts as an 
endogenous “self” ligand for TLR7 which was originally identified as the receptor for 
viral ssRNA 
22-24. 
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Methods 
Mice 
C57BL/6 mice were purchased from Harlan Winkelmann (Borchen, Germany). TLR7-/- 
mice 
25 (4 generations C57BL/6) and TLR3-/- mice 
26 (5 generations C57BL/6) have 
been described. Mice were held according to German guidelines of animal care. 
 
Media and Reagents 
RPMI 1640 (PAA Laboratories, Pasching, Austria) supplemented with 10 % FCS 
(Biochrom, Berlin, Germany), 1 % glutamax, 1% penicillin/streptomycin, 1 % 
nonessential amino acids, 1 % sodium pyruvate (all from Invitrogen, Karlsruhe, 
Germany) and 50 µM β-mercaptoethanol (Sigma, Deisenhofen, Germany) was used as 
complete medium. U1snRNP (which is conserved between species) was purified from 
HeLa cell nuclear extracts as described 
27. U1snRNA was isolated from U1snRNP by 
phenol:chlorophorm:isoamyl alcohol extraction and ethanol precipitation. The anti-Sm 
(B/D) antibody (clone Y12, mouse IgG3 κ isotype 
28 ) was purified from Y12 hybridoma 
supernatant. CpG 2216 oligonucleotide (MWG Biotech, Munich, Germany). Poly I:C 
RNA, Poly U RNA (Amersham Biosciences, Freiburg, Germany) and 
oligoribonucleotides (Curevac, Tübingen, Germany) were used as indicated. RNA 
digestion was performed with 20 µg/ml RNAse A (Sigma, Deisenhofen, Germany) for 1 
hour at 37 ºC.  
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Preparation, culture and stimulation of cells 
BM cells from wildtype and knockout mice were cultured with 20 ng/ml human 
recombinant Flt3L (R&D Systems, Wiesbaden, Germany) in complete medium for 7 
days as described 
29 to generate > 90 % CD11c+ FL-DC with 40 - 50 % 
CD11b
low/CD86
low/B220
high PDC and 40 to 50 % CD11b
high /B220
low DC. For some 
experiments 1000 U/ml murine recombinant IFN-β (PBL Laboratories, Piscataway, NJ, 
USA) was added to the culture at day 6. On day 7 cells were harvested, resuspended in 
fresh medium and seeded at 4 x 10
5 cells/100 µl/well in 96-well plates. For data shown in 
table 1 PDC and conventional DC were isolated from FL-DC by sorting in a MoFlo 
Cytometer (> 97 % purity). PDC were sorted as CD11c+/ CD11b
low/B220
high or 
CD11c+/120G8+/B220
 high cells and conventional DC were sorted as 
CD11c+/CD11b
high/B220
low or CD11c+/120G8-/B220
low DC. The RNAs and the isolated 
U1snRNP were preincubated with DOTAP cationic liposomes (Carl Roth, Karlsruhe, 
Germany) as described 
24. Y12 antibody was incubated with U1snRNP in PBS for 15 min 
on ice plus 5 min at 37 ºC. Stimuli were added in 100 µl volume per well (concentrations 
indicated) for 36 to 40 hrs.  
 
Flow cytometry 
Cells were stained with anti-CD11b-FITC, anti-B220-APC and anti-CD86-PE (BD 
Biosciences, Heidelberg, Germany) and analysed on a FACS Calibur flow cytometer (BD 
Biosciences). Dead cells were excluded from analysis by gating on PI-negative cells.  
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ELISA 
IFN-α was measured in the culture supernatant by ELISA with rat anti-mIFN-α (clone 
RMMA-1) as capture and rabbit anti-mIFN-α as detection Ab (PBL Laboratories) 
followed by Peroxidase-labeled donkey anti-rabbit antiserum (Jackson Immunoresearch, 
Cambridgeshire, UK). Concentrations were calculated from a standard curve of 
recombinant mIFN-α (Hycult, Uden, Netherlands, lower detection limit 1 U/ml). 
Alternatively the mIFN-α ELISA kit from PBL Laboratories was used (indicated in 
figure legend). Murine IL-6 ELISA was performed using matched antibody pairs (clones 
MP5-20F3 and MP5-32C11 from BD Biosciences) and Streptavidin-HRP (Amersham). 
ABTS (2,2’-azino-di-3-ethylbenzthiazoline sulfonate) from Roche Diagnostics 
(Mannheim, Germany) was used as substrate. 
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Results 
Activation of murine dendritic cells by U1snRNP immune complexes  
DC derived from murine BM cells by culture with Flt3L (FL-DC) contain the IFN-α 
producing CD11b
low/B220
high PDC and conventional CD11b
high/B220
low DC. FL-DC 
were incubated with increasing doses of purified U1snRNP complexed with DOTAP 
cationic liposomes or with control stimuli Poly U ssRNA/DOTAP (as TLR7 ligand), Poly 
I:C dsRNA/DOTAP (as ligand for TLR3 and other dsRNA recognition receptors) and 
CpG 2216 oligonucleotide (as TLR9 ligand). U1snRNP induced a robust and dose 
dependent secretion of IFN-α and IL-6 in FL-DC (Figure 1). Cytokine induction by 
U1snRNP required enhanced intracellular delivery, because U1snRNP alone had very 
low immunostimulatory activity (see Figure 2). We tested if complexation with cationic 
liposomes could be replaced by formation of IC, which are internalized by DC via Fc 
receptors. FL-DC, which had been cultured in regular growth medium or with IFN-β for 
the last 18 hours as an enhancer of IFN-α production 
30 were incubated with U1snRNP 
alone or in complex with increasing doses of purified anti-Sm monoclonal antibody Y12 
or Y12 antibody alone. As shown in figure 2, small amounts of IL-6, but very low 
amounts of IFN-α were induced by U1snRNP in the absence of Y12-Ab. Cytokine 
responses increased dose dependently with the concentrations of Y12-Ab added to 
U1snRNP but not with Y12-Ab alone. Preincubation of FL-DC with IFN-β significantly 
enhanced IFN-α production in response to U1snRNP/Y12-Ab IC. As shown in figure 3, 
U1snRNP/Y12-Ab IC induced high level expression of CD86 in most CD11b
high DC and 
in a subpopulation of CD11b
low PDC, which was further enhanced by IFN-β 
preincubation. PDC and conventional DC purified to 97 % by cell sorting were incubated 
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with U1snRNP/Y12-Ab IC. Isolated PDC produced both IFN-α and IL-6 in response to 
U1snRNP IC, whereas isolated conventional DC produced high amounts of IL-6 but IFN-
α was below the detection limit (Table 1). Therefore both PDC and conventional DC 
within FL-DC are directly activated by U1snRNP IC, but PDC are the major source of 
IFN-α in response to U1snRNP IC.  
 
U1snRNP triggers TLR7-dependent and -independent activation pathways 
We hypothesized that U1snRNA could be responsible for the immunostimulatory effect 
of U1snRNP particle. This assumption was tested by comparing the capacity of RNAse 
A-treated and untreated U1snRNP complexed with DOTAP or Y12-Ab to stimulate 
cytokine production and CD86 expression in FL-DC (Figure 4). The ability of U1snRNP 
to induce IFN-α and IL-6 secretion and to upregulate CD86 expression in FL-DC was 
significantly reduced although not completely abrogated by prior digestion of the RNA 
component with RNAse. Overall U1snRNP was less sensitive to RNAse digestion than 
Poly U RNA, which may be due to nuclease protection of U1snRNA within the 
U1snRNP complex.  
 
The 165 nucleotide U1snRNA forms a characteristic secondary structure consisting of  
stem loops I to IV and a 5’-3’ connecting helix 
31. The double helices of stems I, II, III 
and the connecting helix are stacked to form a four-way junction. Single-stranded RNA 
stretches are found in the loops, the conserved Sm-binding site and the 5’terminal 
sequence. TLR3 and TLR7 have been implicated in the recognition of viral double 
stranded and single stranded RNA and could therefore be involved in the DC response to 
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U1snRNP. FL-DC contain 40 to 50 % PDC, which have been shown to express TLR7 but 
not TLR3 and 40 to 50 % conventional DC which express TLR3 and in part also TLR7 
32. The role of TLR3 and TLR7 for recognition of U1snRNP was investigated by 
comparing cytokine production and CD86 upregulation of FL-DC derived from bone 
marrow cells of C57BL/6 wildtype, TLR3-/- and TLR7-/- mice in response to 
U1snRNP/DOTAP and U1snRNP/Y12-Ab IC (Figure 5). Activation of FL-DC by 
U1snRNP-complexes was independent of TLR3 by all parameters measured, while the 
response to Poly I:C was mainly TLR3-mediated. IFN-α and IL-6 production by FL-DC 
in response to U1snRNP complexes were significantly reduced in the absence of TLR7 
similar to the response to Poly U RNA, suggesting that recognition of U1RNA by TLR7 
is mainly responsible for induction of IFN-α and IL-6 by U1snRNP/Y12-Ab IC (Figure 
5A and B). However a small residual IFN-α and IL-6 response to U1snRNP as well as 
Poly U ssRNA was observed in TLR7-deficient FL-DC suggesting the presence of an 
additional recognition mechanisms for ssRNA in FL-DC. This was in contrast to the 
response to imidazoquinolin, which was entirely TLR7-mediated (data not shown). In 
contrast to IFN-α and IL-6 release RANTES and IL-12p40 production induced by 
U1snRNP and Poly U RNA were lower but not significantly reduced in the absence of 
TLR7 (data not shown). Upregulation of CD86 expression by U1snRNP was significantly 
lower but still present in TLR7-deficient cells as compared to WT and TLR3-/- cells 
(figure 5 C).  
 
To verify that the U1snRNA within U1snRNP does indeed act as an endogenous ligand 
for TLR7 we tested the stimulatory capacity of U1snRNA isolated from U1snRNP as 
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well as synthetic oligoribonucleotides derived from the U1snRNA stem loop I, II, IV 
regions and the Sm-binding site (figure 6). The RNAs were transfected into wildtype and 
TLR7-/- FL-DC with cationic liposome DOTAP. Total U1snRNA stimulated IFN-α and 
IL-6 production by FL-DC in a TLR7-dependent manner (1636 +/-753 U/ml IFN-α in 
WT versus 1.8 +/- 0.4 U/ml IFN-α in TLR7-/- FL-DC). Oligoribonucleotides derived 
from stem loop I, II and IV (short and long) as well as from the Sm-binding site were also 
effective stimulators for wildtype, but much less for TLR7-/- FL-DC. The stem I 
oligoribonucleotide, which contained only one uridine in the sequence induced only very 
low levels of cytokines. Incorporation of the naturally occurring 2’O-methyl-adenosine 
instead of the unmodified adenosine in the stem loop II oligonucleotide greatly reduced 
its stimulatory capacity. This 2’O methylation is the only modification of U1snRNA 
outside of the heaviliy modified 5’end. Therefore modifications within the U1snRNA 
sequence may reduce but do not inhibit the immunostimulatory activity of intracellularly 
delivered total U1snRNA. 
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Discussion 
In this study we show that IC containing U1snRNP, a major autoantigen in human and 
murine SLE, stimulates murine BM-derived PDC and conventional DC leading to IFN-α 
and IL-6 production as well as upregulation of costimulatory molecule expression. The 
induction of IFN-α and IL-6 by U1snRNP in FL-DC required the presence of intact 
U1snRNA and was largely dependent on TLR7 but independent of TLR3. U1snRNA 
isolated from U1snRNP and synthetic RNA oligonucleotides derived from the U1snRNA 
sequence directly triggered TLR7-mediated IFN-α and IL-6 release when delivered into 
FL-DC with cationic liposomes. This demonstrates that the U1snRNA within the 
U1snRNP particle can function as an endogenous ligand for TLR7 but not TLR3.  
 
U1snRNP was only active in complex with autoantibody, which binds to Fc receptors and 
thus facilitates internalization into the endosomal compartment as has been shown for 
human SLE IC containing DNA 
20,33. Requirement for IC formation could be bypassed by 
complexation of U1snRNP with cationic liposome, thus ruling out a major contribution 
of Fc receptor signaling for stimulation of PDC by U1snRNP/Y12-Ab complexes. The 
need for enhanced intracellular delivery of autoantigens for immunostimulation however 
may depend on the cell type and the form of autoantigen: Induction of splenocyte 
proliferation by isolated U1snRNA 
34 and Fc receptor-independent, MyD88-independent 
activation of myeloid DC by nucleosomes 
35 have also been reported. The fact that 
U1snRNP or Y12-Ab alone showed only very little effects in FL-DC and and that 
intracellular delivery was required for full stimulatory capacity of U1snRNP also makes 
it unlikely that the cytokine responses and costimulatory molecule upregulation induced 
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by U1snRNP-IC in FL-DC are caused by endotoxin contamination of the U1snRNP or 
the Y12-Ab preparation. In human PDC internalization of SLE-IC was mediated by 
FcγRIIa, which is expressed in a subpopulation of PDC (CD32) 
20,33. This receptor is not 
expressed in mice, but it has been shown in another study that murine myeloid DC 
required FcγRIII expression for activation by chromatin-IC 
19. FcγRI (CD64), which is 
also expressed in murine DC 
36 and has been shown to bind murine IgG3-IC 
37, could be 
responsible for uptake of U1snRNP/Y12-ab IC in our study.  
 
Pretreatment of FL-DC with IFN-βenhanced IFN-α production in response to U1snRNP 
complexes (figure 2 and 6) and the synthetic TLR7-ligand imidazoquinolin (data not 
shown) as has been previously described for human PDC stimulated with SLE-IgG plus 
apoptotic cells 
30. Despite constitutive expression of IRF-7 in PDC, efficient and 
sustained IFN-α  production in PDC also strongly depends on the positive feedback loop 
of type I IFN which leads to IRF-7 upregulation as has been shown by Honda et al. 
38. In 
addition to IRF-7 induction, upregulation of TLR7 by type I IFN stimulation, which has 
been demonstrated for human B lymphocytes 
39 may contribute to the observed 
enhancing effect of IFN-β.  
 
Despite the important role of TLR7 for triggering the IFN-α and IL-6 response to 
U1snRNP in FL-DC, we observed a small residual production of these cytokines in the 
absence of TLR7. Additionally CD86 upregulation induced by U1snRNP was only 
partially TLR7-dependent (figure 5) and the release of RANTES and IL-12p40 in 
response to U1snRNP complexes was only slightly but not significantly reduced in the 
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absence of TLR7 (data not shown). Although it has been suggested that U1snRNA 
induces splenocyte proliferation via TLR3 
34, activation of FL-DC by U1snRNP and 
U1snRNA was TLR3-independent. However other intracellular dsRNA-binding 
molecules such as RIG-I or MDA5 
40, which trigger type I IFN and inflammatory 
cytokine production, could play a role in U1snRNP recognition. Also the response to 
Poly U RNA and synthetic RNA oligonucleotides derived from the U1snRNA sequence 
was not entirely abrogated in TLR7-deficient cells suggesting that ssRNA can trigger 
cytokine responses through an additional unidentified mechanism.  
 
Interestingly a single 2’O-methylation in the U1snRNA stem loop II oligoribonucleotide 
which naturally occurrs in U1snRNA abrogated its immunostimulatory activity in murine 
FL-DC , similar to what has recently been reported for modified synthetic 
oligoribonucleotides in human DC 
41. However intracellularly delivered U1snRNA 
efficiently triggered cytokine release in murine DC despite the presence of modifications 
such as methylations or pseudouridines within the sequence, which suppress the 
immunostimulatory activity of ssRNA 
41. Therefore, although protective mechanisms 
such as RNA modifications are in place, some self RNAs such as U1snRNA, which is 
carried to the TLR7-containing endosomal compartment by internalization of U1snRNP 
autoimmune complexes, can be sensed as a danger signal by immune cells and may 
promote autoimmunity. 
 
Overall this study shows that TLR7 plays an essential role for IFN-α and IL-6 production 
by murine PDC and conventional DC in response to U1snRNP autoantigen. We have thus 
For personal use only. on October 31, 2014.  by guest    www.bloodjournal.org From      16 
 
identified a second mechanism of immunostimulation by nuclear self antigens in addition 
to the recently described triggering of TLR9 by chromatin-containing IC 
4,19,20. Given the 
important role of type I IFN and also IL-6 in human SLE 
16, the recognition of IC 
containing nuclear autoantigens by the endosomally localized TLRs 7 and 9, which leads 
to the induction of these cytokines via a common signalling pathway are attractive targets 
for therapeutic intervention: Pharmacological agents interfering with internalization of 
IC, endosomal maturation, binding of endogenous ligands to TLR7 and TLR9 or with the 
TLR7/9-specific signal tranduction pathway downstream of MyD88 should be promising 
candidates for immunotherapy of SLE . The study of Barrat et al. 
42, which was published 
during revision of this manuscript, shows that specific TLR7 antagonists inhibit IFN-α 
production in human PDC induced by IC formed with anti-RNP antibodies from SLE 
serum and apoptotic cell material, thus supporting our results obtained with purified 
U1snRNP/anti-Sm IC in murine PDC. 
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Table 1
a Cytokine production by sorted plasmacytoid DC and conventional DC 
  Experiment   Plasmacytoid DC  Conventional DC 
#1  1023  < det. limit 
#2  230  < det. limit  IFN-α 
(U/ml) 
#3  215  < det. limit 
#1 377  1900 
#2 152  1121  IL-6 
(pg/ml) 
#3 629  6134 
 
aFL-DC were sorted into PDC and conventional DC (> 97 % purity) as described in the 
methods section and stimulated with IC formed with U1snRNP (20 µg/ml) and anti-Sm 
antibody (100 µg/ml) for 36 hours. IFN-α and IL-6 were measured in the supernatants by 
ELISA. The mIFN-α ELISA kit from PBL Laboratories was used in these experiments. 
Results of three independent experiments are shown. 
 
Figure legends 
Fig. 1  IFN-α and IL-6 induction by U1snRNP/DOTAP complexes in FL-DC 
FL-DC were incubated with U1snRNP/DOTAP complexes (5, 10 and 20 µg/ml 
U1snRNP and 12,5 µg/ml DOTAP) or control stimuli (DOTAP/Poly U 20 µg/ml, 
DOTAP/ Poly I:C 20 µg/ml, CpG 2216 0,5 µM) for 40 hrs. Concentrations of IFN-α and 
IL-6 were measured in the supernatants by ELISA. Results of one representative of 3 
independent experiments are shown. 
 
Fig. 2  IFN-α and IL-6 production in response to U1snRNP/anti-Sm complexes  
IC formed with U1snRNP (20 µg/ml final concentration) and Y12-Ab  or Y12-Ab alone 
(6.25 to 200 µg/ml final concentration) were added to FL-DC, which had been cultured in 
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regular medium or pretreated with IFN-β for 18 hrs. After 36 hrs of incubation IFN-α 
and IL-6 were measured in the supernatant by ELISA. Results of one representative of 
three independent experiments are shown. 
 
Fig. 3 CD86 upregulation by U1snRNP/anti-Sm complexes in FL-DC 
FL-DC (untreated or pretreated with IFN-β) were incubated with Y12-Ab (50 µg/ml) 
alone or in complex with U1snRNP (20 µg/ml) for 40 hrs. CD11b and CD86 expression 
were measured by flow cytometry. Low CD11b expression correlated with high B220 
expression (not shown). Percentages are indicated in the quadrants. One representative of 
four experiments is shown. 
 
Fig. 4  RNAse sensitivity of U1snRNP induced FL-DC activation 
FL-DC (untreated or pretreated with IFN-β) were incubated with untreated or RNAse-
treated Poly U and U1snRNP (20 µg/ml) in complex with DOTAP (12,5 µg/ml or Y12-
Ab (50 µg/ml). Cytokine production was measured by ELISA and CD86 expression 
(expressed as MFI) was determined by flow cytometry. Mean values and standard 
deviations are shown (n=3). Asterisks indicate significant differences between conditions 
with or without RNAse treatment (p-value < 0.05; two-tailed paired Student t-test). 
 
Fig. 5  Influence of TLR7- and TLR3-deficiency on FL-DC activation of by 
U1snRNP  
FL-DC generated from WT, TLR3-/- and TLR7-/- mice were incubated with the 
indicated stimuli (10 µg/ml U1snRNP and Poly U with 12,5 µg/ml DOTAP; 20 µg/ml 
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U1snRNP with 50 µg/ml Y12-Ab; CpG 2216 0.1 µM, Poly I:C 20 µg/ml) for 36 hrs. 
IFN-α (A) and IL-6 (B) were measured in the supernatants by ELISA and CD86 
expression (C) was determined by flow cytometry. Mean values and standard deviations 
are shown (n=3). Asterisks indicate significant differences between WT and TLR7-/- 
cells (p-value < 0.05; two-tailed paired Student t-test). 
 
Fig. 6 TLR7-dependent cytokine induction in FL-DC by total U1snRNA and 
oligoribonucleotides derived from U1snRNA 
WT and TLR7-/- FL-DC were incubated with 10 µg/ml (0.2 µM) total U1snRNA isolated 
from U1snRNP, 2 µM oligoribonucleotides derived from the U1snRNA sequence or 10 
µg/ml Poly U RNA in complex with 12,5 µg/ml DOTAP, with DOTAP alone or with 0.5 
µM CpG 2216 as positive control stimulus. After 36 hours of incubation IFN-α and IL-6 
were measured in the supernatant by ELISA. Mean values and standard deviations are 
shown (n=3). Asterisks indicate significant differences between WT and TLR7-/- cells 
(p-value < 0.05; two-tailed paired Student t-test). 
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